GKIM
IRON icon

GW&K Investment Management’s Disc Medicine IRON Stock Holding History

GW&K Investment Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
+16
New +$1.1K ﹤0.01% 1076

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GW&K Investment Management's IRON Position: Q2 2026 in Review

GW&K Investment Management opened a new position in Disc Medicine (IRON) in Q2 2026: 16 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1076 among its holdings.

215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • GW&K Investment Management held 16 shares of Disc Medicine worth $1K as of Q2 2026.
  • Disc Medicine was a new GW&K Investment Management position in Q2 2026.
  • Disc Medicine made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #1076 holding.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.